Different Acupoints Compatibility Difference of the Effect of Treatment of the Primary Insomnia

NCT02448602 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 333

Last updated 2015-05-21

No results posted yet for this study

Summary

With primary insomnia as the research object, by the method of multi-center RCT and needle single cavity and different acupoints compatibility treatment for primary insomnia, to Pittsburgh sleep quality index(PSQI) and evaluation, sleep log evaluation and Polysomnogram(PSG) as the means, such as the single cavity with different acupoints compatibility evaluate clinical curative effect of treating primary insomnia.

Conditions

  • Primary Insomnia

Interventions

OTHER

acupuncture

Patients will be treated with Shenmen(HT7), needle 1 times a day, 30 min/time, 5 days for a period of treatment, the treatment interval for two days, five intervention treatment, follow-up after 4 weeks.

OTHER

acupuncture

Patients in Sancai coordinated points group, will be treated with Baihui(DU20), Shenmen(HT7), Sanyinjiao(SP6), needle 1 times a day, 30 min/time, 5 days for a period of treatment, the treatment interval for two days, five intervention treatment, follow-up after 4 weeks.

OTHER

acupuncture

Patients in Control group, will be treated with at the junction of deltoid and biceps, needle 1 times a day, 30 min/time, 5 days for a period of treatment, the treatment interval for two days, five intervention treatment, follow-up after 4 weeks.

Sponsors & Collaborators

  • The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine

    collaborator OTHER
  • Hengyang Traditional Chinese Medicine Hospital

    collaborator OTHER
  • Second People's Hospital of Hunan

    collaborator OTHER
  • Jilin University

    collaborator OTHER
  • Qilu Hospital of Shandong University

    collaborator OTHER
  • Changchun University of Chinese Medicine

    lead OTHER

Principal Investigators

  • Fuchun Wang, master · Dean

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2017-12-31
Completion
2018-08-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02448602 on ClinicalTrials.gov